Submitted by Anonymous (not verified) on 2 October 2026 - 10:57
Human medicines European public assessment report (EPAR): Bysumlog, insulin lispro, Date of authorisation: 06/05/2026, Revision: 2, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Bysumlog, insulin lispro, Date of authorisation: 06/05/2026, Revision: 2, Status: Authorised